Image

Global Chronic Disease Management Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Chronic Disease Management Market, By Type (Solution, Services), Solution Type (On-Premise Solution, Cloud-Based Solution, Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service and Others), Disease Indication (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer, Others), End User (Healthcare Providers, Healthcare Payers, Others) – Industry Trends and Forecast to 2029.

Chronic Disease Management Market

Global Chronic Disease Management Market Analysis and Size

Globally, chronic diseases are the primary cause of mortality and disability. Chronic diseases account for about 60% of deaths and 43% of global disease burden, according to the WHO's global status report on non-communicable diseases 2010. Chronic diseases are long-term progressive ailments that are among the most expensive and common healthcare challenges in the world. Chronic disease management is a sort of digital healthcare service that assists healthcare providers in providing educational information to their patients and the implementation of patient- and illness-specific treatment alternatives and regimens. These services are specifically developed to help people manage chronic conditions and lessen their severity.

  • Data Bridge Market Research analyses that the chronic disease management market was valued at USD 6.17 billion in 2021 and is expected to reach USD 20.64 billion by 2029, registering a CAGR of 16.3% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Chronic Disease Management Market Definition

Chronic disease management (CDM) is a type of long-term care and support that provides people with a chronic illness with the medical treatment, knowledge, skills, and resources they need to manage their condition on a daily basis better. Various software and services are mostly responsible for it. By avoiding or decreasing the consequences of the disease through integrated care, chronic disease management aids in lowering healthcare expenditures and enhancing quality of life for those with chronic illnesses.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Solution, Services), Solution Type (On-Premise Solution, Cloud-Based Solution, Web-Based), Service Type (Educational Service, Implementation Service, Consulting Service and Others), Disease Indication (Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer, Others), End User (Healthcare Providers, Healthcare Payers, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

WellSky (US), ZeOmega (India), Health Catalyst (US), Cedar Gate Technologies (US), Cognizant (US), Pegasystems Inc. (US), Epic Systems Corporation (US), Hinduja Global Solutions Ltd. (Bengaluru), NXGN Management, LLC (US), MINES & Associates, Inc. (US), Casenet, LLC (US), ExlServings Holdings, Inc. (US), cliexa, Inc. (Colorado), ScienceSoft USA Corporation (US), Vivify Health, Inc. (Texas), Allscripts Healthcare, LLC (US), Infosys Limited (Bengaluru), Medecision (US), IBM (US), Altruista Health (US), TCS Healthcare Technologies (US), Koninklijke Philips N.V. (Netherlands)

Market Opportunities

 

  • Increase in the number of emerging markets
  • Growing number of service providers
  • Technological advancement

Chronic Disease Management Market Dynamics

Drivers

  • Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, and others will propel the market's growth rate during the forecast period of 2022-2029. Chronic diseases are a major source of concern among the elderly, who are more prone to obesity and diabetes.

  • Rise in the number of geriatric population

The number of persons aged 60 and up has consistently increased over time as a result of rising life expectancy. The worldwide geriatric population will grow from 727 million in 2020 to 1.5 billion by 2050, according to the United Nations Database on World Population Ageing 2020. Geriatric people have the highest risk of suffering from chronic diseases, increasing the demand for the chronic disease management market.

Furthermore, the rise in sedentary lifestyle will act as major factor influencing the growth of chronic disease management market. Along with this, increasing urbanization and rising disposable income are the driving factors accelerating the growth of the chronic disease management market. Also, increasing expenditure on healthcare infrastructure will escalate the growth of chronic disease management market.

Opportunities

  • Technological advancement   

Moreover, the rising adoption rate of advanced technologies will provide beneficial opportunities for the chronic disease management market growth. The rising adoption of health information technologies and the many online resource options available in healthcare are boosting the chronic disease management market.

Moreover, growing number of service providers and increase in the number of emerging markets will further provide beneficial opportunities for the chronic disease management market growth during the forecast period.

Restraints/Challenges Global Chronic Disease Management Market

On the other hand, the high cost associated with managing chronic diseases will further obstruct the growth rate of the chronic disease management market. The dearth of skilled professionals and technical limitations will challenge the chronic disease management market. Additionally, impact of COVID-19 on supply chain and less awareness will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This chronic disease management market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the chronic disease management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Chronic Disease Management Market

The pandemic has forced health systems to focus on the coronavirus's difficulties, such as diminishing personal protective equipment (PPE), rising ICU capacity, and the impact of reduced elective surgeries. These challenges arose mostly as a result of COVID-19 posing an unprecedented task for which much of the industry was unprepared. The spread of COVID-19 has put healthcare organizations under extreme pressure. The adoption of electronic health records by clinicians has proven critical in overcoming that obstacle.

Due to hospital overcrowding and the critical need for social distance to help prevent the transmission of the virus, telehealth adoption has exploded. Telehealth services via patient portals have helped to alleviate hospital overcrowding even more. Furthermore, the COVID-19 outbreak has increased the usage of various digital platforms that assist individuals in gaining better access to medical treatment, which might benefit the care management market and increase demand for chronic disease management solutions.

Recent Development

  • In April 2021, WellSky had announced the launch of an advanced home health visit management solution. CareInsights Guidance is a new component that gives actionable visit utilization insights to help balance treatment quality and patient health improvement. It is expected that the debut of this solution will help their patients and employees and boost the company's sales growth.

Global Chronic Disease Management Market Scope

The chronic disease management market is segmented on the basis of type, solution type, service type, disease indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Solution
  • Services

On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to rising technological advancement in chronic disease management solutions.

Solution Type

  • On-Premise Solution
  • Cloud-Based Solution
  • Web-Based

On the basis of solution type, the chronic disease management market is segmented into on premise solution, cloud-based solution, web-based. In 2021, on premise solution vectors segment is expected to dominate the chronic disease management market due to rising adoption of enterprise application software and enhanced internal processing support.

Service Type

  • Educational Service
  • Implementation Service
  • Consulting Service
  • Others

On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, implementation services segment is expected to dominate the chronic disease management market due to rising research and development activities in various developing countries.

Disease Indication

  • Cardiovascular Diseases (CVD)
  • Diabetes
  • Chronic Obstructive Pulmonary Disorders (COPD)
  • Arthritis
  • Asthma
  • Cancer
  • Others

On the basis of disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer, and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to rising prevalence and incidence of cardiovascular diseases (CVD).

End User

  • Healthcare Providers
  • Healthcare Payers
  • Others

On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers, others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to rise in number of hospitals and advanced healthcare providers in low and middle income countries.

Chronic Disease Management Market Regional Analysis/Insights

The chronic disease management market is analyzed and market size insights and trends are provided by country, test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel as referenced above.

The countries covered in the chronic disease management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the chronic disease management market because of the increasing number of geriatric population and the development of advanced technology in this region. Additionally, growing presence of major market players will flourish the market's growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period of 2022 to 2029 due to the rising presence of chronic diseases management providers.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The chronic disease management market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for chronic disease management market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the chronic disease management market. The data is available for historic period 2010-2020.

Competitive Landscape and Chronic Disease Management Market Share Analysis

The Chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to chronic disease management market.

Some of the major players operating in the chronic disease management market are:

  • WellSky (US)
  • ZeOmega (India)
  • Health Catalyst (US)
  • Cedar Gate Technologies (US)
  • Cognizant (US)
  • Pegasystems Inc. (US)
  • Epic Systems Corporation (US)
  • Hinduja Global Solutions Ltd. (Bengaluru)
  • NXGN Management, LLC (US)
  • MINES & Associates, Inc. (US)
  • Casenet, LLC (US)
  • ExlServings Holdings, Inc. (US)
  • cliexa, Inc. (Colorado)
  • ScienceSoft USA Corporation (US)
  • Vivify Health, Inc. (Texas)
  • Allscripts Healthcare, LLC (US)
  • Infosys Limited (Bengaluru)
  • Medecision (US)
  • IBM (US)
  • Altruista Health (US)
  • TCS Healthcare Technologies (US)
  • Koninklijke Philips N.V. (Netherlands)

Research Methodology : Global Chronic Disease Management Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-chronic-disease-management-market

Customization Available : Global Chronic Disease Management Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Market Value for Chronic Disease Management Market will be USD 20.64 billion by 2029.
The Chronic Disease Management Market is to Grow at a CAGR of 16.3% During the Forecast Period of 2022 to 2029.
WellSky (US), ZeOmega (India), Health Catalyst (US), Cedar Gate Technologies (US), Cognizant (US), Pegasystems Inc. (US), Infosys Limited (Bengaluru), Medecision (US), IBM (US), Altruista Health (US), TCS Healthcare Technologies (US), Koninklijke Philips N.V. (Netherlands) are the Major Companies Operating in Chronic Disease Management Market.
The Countries Covered in the Chronic Disease Management Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Chronic Disease Management Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.